Trends in dispensing and utilisation of sustained-release tapentadol in Australia.

Objectives Tapentadol is a µ-opioid agonist, moderate noradrenaline reuptake inhibitor (NRI) and very weak serotonin reuptake inhibitor. The sustained release (SR) formulation is indicated for relief of chronic moderate to severe pain. We examined utilisation trends and concordance with prescribing...

Full description

Bibliographic Details
Published in:International Journal of Population Data Science
Main Authors: Ximena Camacho, Andrea Schaffer, Nicholas Buckley, Nicole Pratt, Jonathan Brett, David Henry, Sallie-Anne Pearson
Format: Article
Language:English
Published: Swansea University 2022-08-01
Subjects:
Tapentadol
Utilization
Pharmacoepidemiology
Quality use of medicines
Online Access:https://ijpds.org/article/view/1978

Internet

https://ijpds.org/article/view/1978

Similar Items